SA
IONS icon

Sanctuary Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Sanctuary Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
3,938
+20
+0.5% +$1.5K ﹤0.01% 2294
2026
Q1 		$294K Sell
3,918
-584
-13% -$46.1K ﹤0.01% 2114
2025
Q4 		$356K Buy
4,502
+865
+24% +$65.1K ﹤0.01% 1911
2025
Q3 		$238K Buy
+3,637
New +$178K ﹤0.01% 2153
2024
Q4 		– Sell
-9,277
Closed -$316K – 2443
2024
Q3 		$316K Sell
9,277
-7,164
-44% -$333K ﹤0.01% 1956
2024
Q2 		$684K Buy
+16,441
New +$674K 0.01% 1420

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Sanctuary Advisors's IONS Position: Q2 2026 in Review

Sanctuary Advisors increased its Ionis Pharmaceuticals (IONS) stake by 0.51% in Q2 2026, buying an estimated $1.5K and bringing the position to 3,938 shares worth $312K. The position accounts for ﹤0.01% of the portfolio, ranked #2294.

Sanctuary Advisors first reported a position in IONS in Q2 2024 and has held it in 6 quarters since. The position peaked at $684K in Q2 2024. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Sanctuary Advisors held 3,938 shares of Ionis Pharmaceuticals worth $312K as of Q2 2026.
  • Sanctuary Advisors bought 20 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.5K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2294 holding.
  • Sanctuary Advisors first reported a position in Ionis Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • Sanctuary Advisors's Ionis Pharmaceuticals position peaked at $684K in Q2 2024.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.